ACTU (STOCKS)
Actuate Therapeutics, Inc. Common stock
$1.770000
+0.050000 (+2.91%)
Prev close: $1.720000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Daniel M. Schmitt
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $41.97M
- Employees
- 10
- P/E (TTM)
- -1.60
- P/B (TTM)
- 5.05
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.18 | $-0.25 | +0.0699 | +27.97% |
|
Sep 2025 (Q3)
|
$-0.25 | $-0.28 | +0.0331 | +11.69% |
|
Jun 2025 (Q2)
|
$-0.31 | $-0.32 | +0.0113 | +3.52% |
|
Mar 2025 (Q1)
|
$-0.32 | $-0.31 | -0.0106 | -3.43% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $267.46K |
| Operating Expenses | $22.50M |
| Research and Development | $10.29M |
| Other Operating Expenses | $12.20M |
| Operating Income/Loss | -$22.50M |
| Income/Loss From Continuing Operations After Tax | -$22.23M |
| Income/Loss From Continuing Operations Before Tax | -$22.23M |
| Income Tax Expense/Benefit | $800.00 |
| Income Tax Expense/Benefit, Current | $800.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$22.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$22.23M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.23M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.06 |
| Diluted Earnings Per Share | -$1.06 |
| Basic Average Shares | 21,021,817 |
| Diluted Average Shares | 21,021,817 |
| Assets | $14.04M |
| Current Assets | $13.64M |
| Noncurrent Assets | $392.49K |
| Liabilities | $6.11M |
| Current Liabilities | $5.71M |
| Accounts Payable | $1.52M |
| Other Current Liabilities | $4.18M |
| Noncurrent Liabilities | $404.99K |
| Equity | $7.92M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.92M |
| Liabilities And Equity | $14.04M |
| Net Cash Flow From Operating Activities | -$19.21M |
| Net Cash Flow From Operating Activities, Continuing | -$19.21M |
| Net Cash Flow From Investing Activities | -$4.52M |
| Net Cash Flow From Investing Activities, Continuing | -$4.52M |
| Net Cash Flow From Financing Activities | $23.72M |
| Net Cash Flow From Financing Activities, Continuing | $23.72M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$22.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$22.23M |
| Other Comprehensive Income/Loss | $0.00 |